InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: vinmantoo post# 326284

Friday, 04/20/2018 7:31:37 AM

Friday, April 20, 2018 7:31:37 AM

Post# of 345746

The FDA and PPHM both vehemently and definitively disagreed with your assessment.



I disagree and have you not heard the public statements from the FDA tops

...The clinical trials system is "broken" and there needs to be new ways to collect and utilize patient data, Janet Woodcock, director of FDA's Center for Drug Evaluation and Research, told a workshop on real world evidence (RWE) at the National Academies of Sciences, Engineering, and Medicine on Wednesday.
...
...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134829042



Looks like when control arms do not become twisted and broke....some drugs get approved : )
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134882109

Roche still studying the IP and working with Oncologie ?
"Genentech studying Imaging using PGN635(Fhu-Bavi) for the potential “detection of tumor response to therapy”. 9 Genentech co-authors of new paper pub. 10-12-2012 in Nuclear Medicine & Biology, which acknowledges Dr. Philip Thorpe & Peregrine, and states in the article, “the presented PS-targeting antibody (89Zr-PGN635) has a potential to become a broadly applicable imaging agent indep. on cancer type since PS is a generic component of the plasma membrane.”… [Thanks, FTM – great find]… "
https://www.investorvillage.com/mbthread.asp?mb=1773&tid=12202982&showall=1

Why did the new BODs not go public with an open bidding system ? Roche reasons possibly I would say

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News